Congratulations to Sophie Mepham on IAOCR President Appointment – APAC Chapter
This prestigious role recognises Sophie’s outstanding leadership and commitment to advancing global standards in clinical research.
Her appointment comes at a pivotal time, following Icon’s achievement as the first Australian organisation to secure dual global quality certifications for research sites and workforce leadership.
These accreditations reflect Icon’s dedication to upholding patient safety, delivering high-quality clinical trials, and fostering a culture of excellence across our research network.
Sophie is excited for this new appointment.
“I’m honoured to represent the APAC region and commercial research sites at a global level,” said Sophie.
“This is an exciting opportunity to collaborate with industry leaders, share best practices, and help raise the bar for clinical research quality and workforce development.
“I look forward to working with colleagues across the region to ensure patients everywhere benefit from world-class research and innovation.”
For Icon, this appointment reinforces our position as a leader in quality research and operational excellence. It will enable us to contribute even more actively to the development of global frameworks, share our learnings, and collaborate with industry partners to improve patient outcomes and accelerate the delivery of new therapies to more people and regions.
On behalf of everyone at Icon, congratulations Sophie – your passion and expertise continue to inspire us and drive progress for patients, researchers, and the wider clinical research community.
About Icon Group
Icon Group is Australia’s largest dedicated cancer care provider and has expanded globally into New Zealand, Asia and the United Kingdom.
Our people
People from across Icon Group share their stories of success, career progression and being iconic.
A career with Icon
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Updates
Read the latest news and updates across Icon Group.